ScreenPoint Medical news
It follows a year of major achievements for the organisation with Transpara which is now installed in health care facilities both across the US and in over 25 countries worldwide.
The success of FDA cleared Transpara AI has been marked by a record number of peer reviewed papers and well over 2,000,000 mammograms being read by this unique system.
Transpara`s developers, ScreenPoint Medical is expanding its operations in the US to meet customer demand and its success has meant t
Transpara, the world`s leading artificial intelligence (AI) breast care software, has now reached a major new milestone, helping radiologists read over three million mammograms.
Across the US, Transpara is providing hundreds of radiologists with a `second pair` of eyes helping detect cancers earlier and reduce recall rates.
Among the radiologists using this revolutionary AI breast care system, is Dr Englander, Chairman, Pennsylvania Hospital, Department of Radiology.
"
The Transpara AI breast care solution, now being used in over 30 countries worldwide to find breast cancers faster and earlier, has `remarkable potential` to reduce Radiologists` workload, according to a leading research team in Spain.
The team at the renowned University Hospital Reina Sofia in Cordoba, has launched a world first prospective 2D AND 3D study to see how they could help over-stretched breast
The team running the country`s largest breast screening programme have shown that using Transpara breast AI further confirmed the enormous contribution of this technology to breast cancer detection: not only to reduce the number of false positives but also to reduce radiologists` workload by over 60%.
In Copenhagen, the biannual breast screening programme for women aged from 50 to 69, has been running for over 30 years. Mammograms in the screening progra
The Cancer Registry of Norway is one of the oldest and most respected organisations of its kind in the world. It collects data and produces statistics of the cancer prevalence in Norway, has the administrative responsibility for the public screening programme in Norway and has an extensive research activity.
In a recent study, the Registry used over 120,000
Following the success of the world`s leading AI Breast Care system, Transpara®, now in use across the US and in 30 countries worldwide, ScreenPoint Medical, the company that developed Transpara, has appointed Mark Koeniguer as its new CEO to lead the next phase of growth and accelerate the company`s international expansion.
Koeniguer, who has extensive experience leading and growing transformational technol
ScreenPoint Medical`s Transpara AI decision support system can help radiologists to identify potential breast cancers earlier and faster, according to a new study published in Radiology. The ground breaking evidence-based software is already in clinical use in over 30 countries including the USA, France, Germany and Spain.
The incidence of breas
Following the success of the world`s leading AI Breast Care system, Transpara®, now in use across the US and in 30 countries worldwide, ScreenPoint Medical, the company that developed Transpara, is to launch a major expansion.
The FDA and CE marked Transpara AI software reads mammograms to find cancers faster and at an earlier stage. 2022 will see a larger global team and further research and development resulting in an expansion of ScreenPoint`s product portfolio. ScreenPoi